Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Feb-24 7:57 PM View:  | Ostrowski Erik Interim CEO, President and CFO | Avrobio, Inc. (AVRO) | 05-Feb-24 | Payment of Exercise | 13,099 | $1.20 | $15,745.00 | (31%) 42.38K to 29.29K | |
| 05-Feb-24 7:59 PM View: | Ridha Essra Chief Medical Officer | Avrobio, Inc. (AVRO) | 05-Feb-24 | Payment of Exercise | 16,953 | $1.20 | $20,353.80 | (52%) 32.83K to 15.88K | |
| 05-Feb-24 7:56 PM View: | Avruch Steven Chief Legal Officer | Avrobio, Inc. (AVRO) | 05-Feb-24 | Payment of Exercise | 10,812 | $1.20 | $12,996.00 | (33%) 32.83K to 22.02K | |
| 05-Feb-24 8:01 PM View: | Golipour Azadeh Chief Technology Officer | Avrobio, Inc. (AVRO) | 05-Feb-24 | Payment of Exercise | 12,232 | $1.20 | $14,698.00 | (18%) 68.1K to 55.87K | |
| 05-Feb-24 7:59 PM View: | Ridha Essra Chief Medical Officer | Avrobio, Inc. (AVRO) | 01-Feb-24 | Option Exercise | 32,834 | -- | -- | 100% 0 to 32.83K | |
| 05-Feb-24 7:56 PM View: | Avruch Steven Chief Legal Officer | Avrobio, Inc. (AVRO) | 01-Feb-24 | Option Exercise | 32,834 | -- | -- | 100% 0 to 32.83K | |
| 05-Feb-24 8:01 PM View: | Golipour Azadeh Chief Technology Officer | Avrobio, Inc. (AVRO) | 01-Feb-24 | Option Exercise | 37,334 | -- | -- | 121% 30.77K to 68.1K | |
| 05-Feb-24 7:57 PM View: | Ostrowski Erik Interim CEO, President and CFO | Avrobio, Inc. (AVRO) | 01-Feb-24 | Option Exercise | 40,084 | -- | -- | 1743% 2.3K to 42.38K | |
| 13-Jun-23 4:32 PM View: | Golipour Azadeh Chief Technology Officer | Avrobio, Inc. (AVRO) | 12-Jun-23 | Payment of Exercise | 5,574 | $1.19 | $6,634.73 | (15%) 36.34K to 30.77K | |
| 26-Jan-23 5:30 PM View: | MacKay Geoffrey President & CEO Director | Avrobio, Inc. (AVRO) | 24-Jan-23 | Option Exercise | 45,999 | $0.91 | $41,859.10 | 6% 732.34K to 778.34K | |
| 26-Jan-23 5:30 PM View: | MacKay Geoffrey President & CEO Director | Avrobio, Inc. (AVRO) | 28-Dec-22 | Gift | 245,123 | -- | -- | 33% 732.34K to 977.47K | |
| 26-Jan-23 5:30 PM View: | MacKay Geoffrey President & CEO Director | Avrobio, Inc. (AVRO) | 28-Dec-22 | Gift | 245,123 | -- | -- | (25%) 977.47K to 732.34K | |
| 28-Dec-22 7:18 PM View: | MacKay Geoffrey President & CEO Director | Avrobio, Inc. (AVRO) | 23-Dec-22 | Option Exercise | 142,013 | $0.41 | $58,679.80 | 24% 590.33K to 732.34K | |
| 08-Jul-21 4:21 PM View: | Vickers Philip J. Director | Avrobio, Inc. (AVRO) | 07-Jul-21 | Market Purchase | 4,800 | $8.35 | $40,080.00 | 100% 0 to 4.8K | < 1% |
| 18-Feb-21 7:06 PM View: | Donenberg Philip B Director | Avrobio, Inc. (AVRO) | 17-Feb-21 | Market Purchase | 2,000 | $11.71 | $23,420.00 | 100% 0 to 2.0K | < 1% |
| 28-Dec-20 7:46 PM View: | MacKay Geoffrey President & CEO Director | Avrobio, Inc. (AVRO) | 24-Dec-20 | Option Exercise | 100,000 | $0.41 | $41,320.00 | 20% 490.33K to 590.33K | |
| 18-Feb-20 9:51 PM View: | Atlas Venture Associates X,... 10% Owner | Avrobio, Inc. (AVRO) | 13-Feb-20 | Disposition (other) | 1,046,430 | -- | -- | (22%) 4.76M to 3.71M | |
| 14-Feb-20 7:16 PM View: | MacKay Geoffrey See Remarks Director | Avrobio, Inc. (AVRO) | 12-Feb-20 | Market Sale (Planned) | 1,400 | $29.07 | $40,692.00 | (< 1%) 491.73K to 490.33K | 49% |
| 11-Feb-20 9:23 PM View: | MacKay Geoffrey See Remarks Director | Avrobio, Inc. (AVRO) | 11-Feb-20 | Market Sale (Planned) | 63,000 | $27.57 | $1,737,080.00 | (11%) 554.73K to 491.73K | 46% |
| 11-Feb-20 9:26 PM View: | Paige Christopher Director | Avrobio, Inc. (AVRO) | 11-Feb-20 | Market Sale (Planned) | 15,000 | $28.00 | $420,000.00 | (6%) 267.51K to 252.51K | 47% |
| 30-Jan-20 4:10 PM View: | Paige Christopher Director | Avrobio, Inc. (AVRO) | 28-Jan-20 | Market Sale (Planned) | 10,000 | $23.00 | $230,000.00 | (4%) 277.51K to 267.51K | 36% |
| 14-Feb-20 10:00 PM View: | MacKay Geoffrey See Remarks Director | Avrobio, Inc. (AVRO) | 29-Jul-19 | Gift | 200,000 | -- | -- | (29%) 690.33K to 490.33K | |
| 23-Jul-19 4:09 PM View: | Atlas Venture Fund X, L.P. 10% Owner | Avrobio, Inc. (AVRO) | 19-Jul-19 | Private Purchase Duplicate | 810,811 | $18.50 | $15,000,000.00 | 17% 4.76M to 5.57M | |
| 23-Jul-19 4:09 PM View: | Booth Bruce Director | Avrobio, Inc. (AVRO) | 19-Jul-19 | Private Purchase | 810,811 | $18.50 | $15,000,000.00 | 17% 4.76M to 5.57M | |
| 22-May-19 9:02 PM View: | Clarus Lifesciences Iii, L.P. 10% Owner | Avrobio, Inc. (AVRO) | 20-May-19 | Disposition (other) | 1,481,160 | -- | -- | (50%) 2.96M to 1.48M | |
| 09-Apr-19 4:39 PM View: | Paige Christopher Director | Avrobio, Inc. (AVRO) | 08-Apr-19 | Market Sale (Planned) | 2,500 | $25.89 | $64,713.30 | (< 1%) 280.01K to 277.51K | 43% |
| 09-Apr-19 4:27 PM View: | MacKay Geoffrey See Remarks Director | Avrobio, Inc. (AVRO) | 08-Apr-19 | Market Sale (Planned) | 698 | $27.07 | $18,893.30 | (< 1%) 555.43K to 554.73K | 45% |
| 09-Apr-19 4:27 PM View: | MacKay Geoffrey See Remarks Director | Avrobio, Inc. (AVRO) | 05-Apr-19 | Market Sale (Planned) | 13,302 | $27.26 | $362,618.00 | (2%) 568.73K to 555.43K | 46% |
| 09-Apr-19 4:39 PM View: | Paige Christopher Director | Avrobio, Inc. (AVRO) | 05-Apr-19 | Market Sale (Planned) | 7,500 | $25.66 | $192,483.00 | (3%) 287.51K to 280.01K | 43% |
| 18-Jan-19 5:00 PM View: | Svlsf Vi, LLC 10% Owner | Avrobio, Inc. (AVRO) | 16-Jan-19 | Disposition (other) | 805,323 | -- | -- | (29%) 2.74M to 1.93M | |
| 04-Jan-19 4:28 PM View: | Ostrowski Erik Chief Financial Officer | Avrobio, Inc. (AVRO) | 02-Jan-19 | Grant | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 10-Oct-18 6:11 PM View: | Dorton Katina Chief Financial Officer | Avrobio, Inc. (AVRO) | 08-Oct-18 | Option Exercise | 10,000 | $0.91 | $9,100.00 | 100% 0 to 10.0K | |
| 10-Oct-18 6:05 PM View: | Kreher Nerissa Chief Medical Officer | Avrobio, Inc. (AVRO) | 08-Oct-18 | Option Exercise | 2,942 | $0.91 | $2,677.22 | 100% 0 to 2.94K | |
| 25-Jun-18 6:15 PM View: | Booth Bruce Director | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion | 4,756,480 | -- | -- | 100% 0 to 4.76M | |
| 25-Jun-18 6:18 PM View: | Requadt Scott Director | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion Duplicate | 2,962,320 | -- | -- | 100% 0 to 2.96M | |
| 25-Jun-18 6:15 PM View: | Clarus Lifesciences Iii, L.P. 10% Owner | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion | 2,962,320 | -- | -- | 100% 0 to 2.96M | |
| 25-Jun-18 6:22 PM View: | Atlas Venture Fund X, L.P. 10% Owner | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion Duplicate | 4,756,480 | -- | -- | 100% 0 to 4.76M | |
| 25-Jun-18 6:16 PM View: | Svlsf Vi, LLC 10% Owner | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion | 2,736,030 | -- | -- | 100% 0 to 2.74M |
